Correlation Between Pfizer and DiaMedica Therapeutics

Can any of the company-specific risk be diversified away by investing in both Pfizer and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and DiaMedica Therapeutics, you can compare the effects of market volatilities on Pfizer and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and DiaMedica Therapeutics.

Diversification Opportunities for Pfizer and DiaMedica Therapeutics

-0.48

Correlation Coefficient

Pfizer  DiaMedica Therapeutics

Very good diversification

The 3 months correlation between Pfizer and DiaMedica is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Pfizer i.e., Pfizer and DiaMedica Therapeutics go up and down completely randomly.

Pair Corralation between Pfizer and DiaMedica Therapeutics

Considering the 90-day investment horizon Pfizer is expected to generate 2.62 times less return on investment than DiaMedica Therapeutics. But when comparing it to its historical volatility, Pfizer Inc is 5.32 times less risky than DiaMedica Therapeutics. It trades about 0.12 of its potential returns per unit of risk. DiaMedica Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  508.00  in DiaMedica Therapeutics on September 27, 2024 and sell it today you would earn a total of  18.00  from holding DiaMedica Therapeutics or generate 3.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  DiaMedica Therapeutics

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

DiaMedica Therapeutics

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, DiaMedica Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pfizer and DiaMedica Therapeutics

The main advantage of trading using opposite Pfizer and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.

The idea behind Pfizer Inc and DiaMedica Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.